Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
1,362
+44
+3% +$9.47K 0.12% 83
2026
Q1
$287K Sell
1,318
-3
-0.2% -$665 0.11% 88
2025
Q4
$302K Buy
1,321
+20
+2% +$4.56K 0.12% 86
2025
Q3
$301K Sell
1,301
-25
-2% -$5.09K 0.11% 90
2025
Q2
$246K Buy
1,326
+27
+2% +$5.02K 0.1% 95
2025
Q1
$272K Buy
1,299
+72
+6% +$14K 0.1% 86
2024
Q4
$218K Sell
1,227
-375
-23% -$68.9K 0.08% 97
2024
Q3
$316K Hold
1,602
0.08% 123
2024
Q2
$275K Hold
1,602
0.07% 130
2024
Q1
$292K Hold
1,602
0.08% 126
2023
Q4
$248K Buy
1,602
+138
+9% +$20.1K 0.07% 130
2023
Q3
$218K Buy
+1,464
New +$215K 0.07% 131
2023
Q2
Sell
-1,380
Closed -$220K 143
2023
Q1
$220K Buy
1,380
+66
+5% +$10.1K 0.07% 134
2022
Q4
$212K Buy
+1,314
New +$201K 0.07% 126
2022
Q3
Sell
-1,449
Closed -$222K 111
2022
Q2
$222K Hold
1,449
0.08% 107
2022
Q1
$235K Buy
+1,449
New +$210K 0.07% 112
2018
Q1
Sell
-2,108
Closed -$204K 83
2017
Q4
$204K Buy
+2,108
New +$199K 0.16% 80

Other funds holding ABBV

REDW Wealth's ABBV Position: Q2 2026 in Review

REDW Wealth increased its AbbVie (ABBV) stake by 3.3% in Q2 2026, buying an estimated $9.47K and bringing the position to 1,362 shares worth $343K. The position accounts for 0.12% of the portfolio, ranked #83.

REDW Wealth first reported a position in ABBV in Q4 2017 and has held it in 17 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • REDW Wealth held 1,362 shares of AbbVie worth $343K as of Q2 2026.
  • REDW Wealth bought 44 AbbVie shares in Q2 2026, an estimated $9.47K.
  • AbbVie made up 0.12% of REDW Wealth's portfolio in Q2 2026, its #83 holding.
  • REDW Wealth first reported a position in AbbVie in Q4 2017 and has held it in 17 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on REDW Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.